Nosopharm
Created in 2009
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
411 1,940Activities
Technologies
Entity types
Location
21 Av. Georges Pompidou, 69003 Lyon, France
Lyon
France
Employees
Scale: 2-10
Estimated: 7
SIREN
510425432Engaged corporates
12
10 2Added in Motherbase
5 years, 7 months ago
biotech Value proposition
Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR).
The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs.
The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus.
Anti-Infectives, Drug Discovery, Antibiotics, and MicrobiologyOriginal language
Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR).
The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs.
The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus.
Nosopharm | First-in-class Anti-Infectives
https://www.nosopharm.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Elaia Startup accelerator & VC, Venture Capital and Private Equity Principals | Capitalistic Not partnership Not event 27 Mar 2023 | | |
 INRAE Research, Research Services | INRAE Research, Research Services | Not capitalistic Partnership Not event 31 Mar 2022 | | |